United Kingdom HbA1c Market Insight
The United Kingdom HbA1cMarket is growing at an 11.46%CAGR, driven by rising diabetes prevalence, screening programs, NHS initiatives, point-of-care testing and digital diagnostics.
United KingdomHbA1c Market Insights Forecasts to 2035
- The United KingdomHbA1c Market Size Was Estimated at USD 2.01Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 11.46% from 2025 to 2035
- The United Kingdom HbA1c Market Size is Expected to Reach USD 5.95Billion by 2035
Notable Insightsfor United KingdomHbA1c Market
- By product type, laboratory analyzers dominated, accounting for approximately 72% share in 2024, driven by high accuracy and NHS hospital adoption.
- BY testing method, HPLC-based HbA1c testing led the market, holding approximately65% share, due to reliability in long-term glucose monitoring.
- Around7% of the UK adult population is living with diabetes, supporting consistent demand for HbA1c testing services.
- Nearly 80% of diagnosed diabetic patients undergo routine HbA1c testing at least twice annually under NHS guidelines for disease management.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom HbA1cMarket, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom HbA1c Market
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Bio-Rad Laboratories
- Danaher Corporation
- Tosoh Corporation
- ARKRAY
- Trinity Biotech
- EKF Diagnostics
- Others
Recent Developments:
- In April 2026, Avricore Health expanded HealthTab HbA1c testing across 57 London pharmacies in Q1 2026, completing 2,295 tests, with UK expansion planned to 500+ sites supporting NHS diabetes screening initiatives.
- In August 2025, UK-based PocDoc launched its smartphone Diabetes Health Check, enabling HbA1c-based type 2 diabetes risk screening in homes, workplaces, and communities for early detection and prevention.
Market Segmentation:
United Kingdom HbA1c Market, By Product Type
- Laboratory Analyzers
- Point-of-Care Devices
- Reagents & Consumables
- Others
United Kingdom HbA1c Market, By Testing Method
- High-Performance Liquid Chromatography (HPLC)
- Immunoassay
- Enzymatic Assay
- Others
United Kingdom HbA1c Market, By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care Settings
- Specialty Diabetes Centers
United Kingdom HbA1c Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Channels
Expert Views:
The UK HbA1c Market is expected to grow steadily due to rising diabetes prevalence, expanding NHS screening initiatives, and increasing awareness of early glycemic control. Experts highlight that laboratory-based HbA1c testing will continue to dominate, supported by clinical accuracy requirements and guideline-driven monitoring. However, rapid adoption of point-of-care devices and digital health integration is expected to transform decentralized diabetes care and improve real-time patient management through 2035.